News & Updates

Show Multimedia Only

Transforming ischaemic stroke care: Integrated networks, thrombolysis optimization and AI-assisted hyperacute care

13 Jan 2026 by

Acute ischaemic stroke remains a time-critical medical emergency in which rapid diagnosis, efficient prehospital triage, and timely reperfusion therapy are central to reducing mortality and long-term disability. At the Hong Kong Stroke Society Annual Scientific Meeting 2025, Dr David Hargroves of the East Kent Hospitals University Foundation Trust, UK, outlined England’s 7-year, system-wide quality improvement programme in acute stroke care, delivered through the Getting It Right the First Time (GIRFT) initiative.

Transforming ischaemic stroke care: Integrated networks, thrombolysis optimization and AI-assisted hyperacute care

13 Jan 2026

Long COVID linked to myasthenia gravis exacerbation

12 Jan 2026 by

For patients with myasthenia gravis, long COVID has been reported to be a risk factor for disease exacerbation in a recent study from China.

Long COVID linked to myasthenia gravis exacerbation

12 Jan 2026

Tai chi noninferior to CBT-I for long-term management of insomnia

12 Jan 2026 by

Tai chi practice is noninferior to cognitive behavioural therapy for insomnia (CBT-I) in sustaining beneficial improvements at month 15 among middle-aged and older adults with chronic insomnia, researchers from the School of Public Health at the University of Hong Kong (HKU) found.

Tai chi noninferior to CBT-I for long-term management of insomnia

12 Jan 2026

Sooner is better when initiating DAPT after minor stroke or high-risk TIA

12 Jan 2026

Initiating dual antiplatelet therapy (DAPT) within 24 h of onset of a minor ischaemic stroke or transient ischaemic attack (TIA) yields the greatest clinical benefit, with the therapeutic effect declining progressively beyond this period, as shown in a study.

Sooner is better when initiating DAPT after minor stroke or high-risk TIA

12 Jan 2026

Six depressive symptoms in midlife may pinpoint increased dementia risk

12 Jan 2026 by

Six depressive symptoms in midlife are associated with an increased risk of dementia, a 23-year UK prospective cohort study has shown.

Six depressive symptoms in midlife may pinpoint increased dementia risk

12 Jan 2026

Endocan, miR-221 predict development of diabetic neuropathy

09 Jan 2026 by

Endocan and miR-221 expression levels are significantly associated with development of neuropathy in patients with diabetes, indicating their potential role as biomarkers to diagnose diabetic peripheral neuropathy (DPN) at an early stage before the development of clinical manifestations, reports a study presented at ATTD-Asia 2025.

Endocan, miR-221 predict development of diabetic neuropathy

09 Jan 2026

Intravenous thrombolysis safe, beneficial for stroke patients with recent DOAC use

09 Jan 2026

In the treatment of acute ischaemic stroke in patients with recent direct oral anticoagulant (DOAC) use, intravenous thrombolysis appears to be safe and is associated with improvements in functional outcomes, according to a study.

Intravenous thrombolysis safe, beneficial for stroke patients with recent DOAC use

09 Jan 2026

Flu vaccination exerts no influence on PD risk

08 Jan 2026

Influenza immunization at midlife neither increases nor reduces the risk of Parkinson’s disease (PD), as shown in a study.

Flu vaccination exerts no influence on PD risk

08 Jan 2026

Topiramate tied to weight loss vs other antiseizure drugs

06 Jan 2026

Among commonly used antiseizure medications (ASMs), topiramate appears to result in weight loss at 6 and 12 months under either initiation and subsequent adherence or initiation-only effects, reports a study. Other ASMs seem to contribute to greater weight change.

Topiramate tied to weight loss vs other antiseizure drugs

06 Jan 2026

Original New Drug Application Approvals by US FDA (16-31 December 2025)

06 Jan 2026

New drug applications approved by US FDA as of 16-31 December 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 December 2025)

06 Jan 2026

News & Updates

Showing Neurology articles

Showing

Specialty:

Transforming ischaemic stroke care: Integrated networks, thrombolysis optimization and AI-assisted hyperacute care

Transforming ischaemic stroke care: Integrated networks, thrombolysis optimization and AI-assisted hyperacute care

Long COVID linked to myasthenia gravis exacerbation

Long COVID linked to myasthenia gravis exacerbation

Tai chi noninferior to CBT-I for long-term management of insomnia

Tai chi noninferior to CBT-I for long-term management of insomnia

Sooner is better when initiating DAPT after minor stroke or high-risk TIA

Sooner is better when initiating DAPT after minor stroke or high-risk TIA

Six depressive symptoms in midlife may pinpoint increased dementia risk

Six depressive symptoms in midlife may pinpoint increased dementia risk

Endocan, miR-221 predict development of diabetic neuropathy

Endocan, miR-221 predict development of diabetic neuropathy

Intravenous thrombolysis safe, beneficial for stroke patients with recent DOAC use

Intravenous thrombolysis safe, beneficial for stroke patients with recent DOAC use

Flu vaccination exerts no influence on PD risk

Flu vaccination exerts no influence on PD risk

Topiramate tied to weight loss vs other antiseizure drugs

Topiramate tied to weight loss vs other antiseizure drugs

Original New Drug Application Approvals by US FDA (16-31 December 2025)

Original New Drug Application Approvals by US FDA (16-31 December 2025)